• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同免疫细胞及其细胞因子在人体内脏利什曼病中的作用及相互关系。

Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis.

机构信息

Infectious Diseases and Immunology, Indian Institute of Chemical Biology, West Bengal, India.

出版信息

Rev Soc Bras Med Trop. 2013 Mar-Apr;46(2):128-34. doi: 10.1590/0037-8682-0022-2012.

DOI:10.1590/0037-8682-0022-2012
PMID:23559342
Abstract

Visceral leishmaniasis (VL) or kala-azar, a disseminated infection of the lymphoreticular system of the body, is marked by severe defect in immune system of the host. Successful cure of VL depends on the immune status of the host in combination with the effects of the antileishmanial drugs. The rationale approach towards eradication of this disease would be to potentiate the immune functioning of the host in addition to parasite killing. This review deals with different aspects of adaptive and innate immune responses and explores their role in protection or pathogenesis of VL. IL-10 has emerged as the principal cytokine responsible for disease pathogenesis, although evidences regarding its source during active VL remain inconclusive. On the other hand, IFNγ,under the influence of IL-12, is mostly correlated with healing of the disease. Chemokines are important in mounting cell-mediated immune response as they can prevent parasite invasion in association with cytokines. Different types of T cells like CD4, CD8 and NK T cells also contribute to the immunology of this disease. In spite of conflicting reports, the role of regulatory T cells in VL pathogenesis is important. Recently discovered Th17 subset and its different members have been reported to perform diverse functions in the course of VL and leishmaniasis as a whole. Innate immune responses, depending on the cell types, are essential in early parasite detection and subsequent development of an efficient NK cell response. Immunotherapy targeting IL-10 could be looked upon as an interesting option for the treatment of VL.

摘要

内脏利什曼病(VL)或黑热病,是一种身体淋巴网状系统的弥散性感染,其特征是宿主免疫系统严重缺陷。VL 的成功治愈取决于宿主的免疫状态以及抗利什曼原虫药物的作用。消除这种疾病的合理方法是增强宿主的免疫功能,同时杀死寄生虫。这篇综述涉及适应性和固有免疫反应的不同方面,并探讨了它们在保护或 VL 发病机制中的作用。IL-10 已成为导致疾病发病机制的主要细胞因子,尽管关于其在活动性 VL 期间的来源的证据仍不确定。另一方面,IFNγ在 IL-12 的影响下,与疾病的治愈大多相关。趋化因子在引发细胞介导的免疫反应中很重要,因为它们可以与细胞因子一起防止寄生虫入侵。不同类型的 T 细胞,如 CD4、CD8 和 NK T 细胞,也有助于这种疾病的免疫学。尽管存在相互矛盾的报告,但调节性 T 细胞在 VL 发病机制中的作用很重要。最近发现的 Th17 亚群及其不同成员已被报道在 VL 及整个利什曼病的病程中发挥不同的功能。根据细胞类型,固有免疫反应对于早期寄生虫检测和随后发展有效的 NK 细胞反应至关重要。针对 IL-10 的免疫疗法可能被视为治疗 VL 的一种有趣选择。

相似文献

1
Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis.不同免疫细胞及其细胞因子在人体内脏利什曼病中的作用及相互关系。
Rev Soc Bras Med Trop. 2013 Mar-Apr;46(2):128-34. doi: 10.1590/0037-8682-0022-2012.
2
Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome.人类内脏利什曼病中的免疫反应:先天免疫细胞因子谱与疾病结局之间的相关性分析。
Scand J Immunol. 2005 Nov;62(5):487-95. doi: 10.1111/j.1365-3083.2005.01686.x.
3
Chemokines in host-parasite interactions in leishmaniasis.利什曼病宿主-寄生虫相互作用中的趋化因子
Trends Parasitol. 2006 Jan;22(1):32-40. doi: 10.1016/j.pt.2005.11.010. Epub 2005 Nov 23.
4
Immunobiology of leishmaniasis.利什曼病的免疫生物学
Indian J Exp Biol. 2009 Jun;47(6):412-23.
5
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.细胞因子:内脏利什曼病耐药或疾病进展的关键决定因素:新型诊断和免疫治疗的机会。
Front Immunol. 2019 Apr 5;10:670. doi: 10.3389/fimmu.2019.00670. eCollection 2019.
6
Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.杜氏利什曼原虫与免疫:在内脏利什曼病中,来自一名供体的利什曼原虫致敏的T细胞在用来自不同供体的利什曼原虫再次刺激时,可能会调节其细胞因子模式。
Exp Parasitol. 2009 Jan;121(1):69-75. doi: 10.1016/j.exppara.2008.09.015. Epub 2008 Oct 7.
7
Cytokine saga in visceral leishmaniasis.内脏利什曼病中的细胞因子传奇。
Cytokine. 2021 Nov;147:155322. doi: 10.1016/j.cyto.2020.155322. Epub 2020 Oct 28.
8
[Immunopathology of American tegumentary leishmaniasis].[美洲皮肤利什曼病的免疫病理学]
Acta Cient Venez. 1998;49(1):42-56.
9
Role of leptin in human visceral leishmaniasis?瘦素在人类内脏利什曼病中的作用?
Med Hypotheses. 2011 Sep;77(3):416-8. doi: 10.1016/j.mehy.2011.05.032. Epub 2011 Jul 2.
10
Post-kala-azar dermal leishmaniasis--an overview.Post-kala-azar dermal leishmaniasis--an overview.
Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x.

引用本文的文献

1
CD4 Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis.CD4 Th1 和 Th17 反应以及多功能 CD8 T 淋巴细胞与人类内脏利什曼病的治愈或病情恶化有关。
Front Immunol. 2024 Feb 12;15:1277557. doi: 10.3389/fimmu.2024.1277557. eCollection 2024.
2
Immunogenicity and protective efficacy of tuzin protein as a vaccine candidate in -infected BALB/c mice.图津蛋白作为候选疫苗在感染的BALB/c小鼠中的免疫原性和保护效力。
Front Immunol. 2024 Jan 11;14:1294397. doi: 10.3389/fimmu.2023.1294397. eCollection 2023.
3
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
一种免疫原性嵌合蛋白加佐剂与两性霉素B联合免疫疗法治疗小鼠内脏利什曼病的疗效
Biology (Basel). 2023 Jun 13;12(6):851. doi: 10.3390/biology12060851.
4
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis.免疫疗法和免疫化学疗法对抗内脏利什曼病
Front Med (Lausanne). 2023 May 17;10:1096458. doi: 10.3389/fmed.2023.1096458. eCollection 2023.
5
Amphotericin B Nano-Assemblies Circumvent Intrinsic Toxicity and Ensure Superior Protection in Experimental Visceral Leishmaniasis with Feeble Toxic Manifestation.两性霉素B纳米组装体可规避内在毒性,并在实验性内脏利什曼病中确保具有微弱毒性表现的卓越保护作用。
Vaccines (Basel). 2023 Jan 1;11(1):100. doi: 10.3390/vaccines11010100.
6
A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.CD4+ T 细胞亚群在皮肤利什曼病和内脏利什曼病免疫反应发展中的作用的历史性回顾。
Iran Biomed J. 2022 Mar 1;26(2):99-109. doi: 10.52547/ibj.26.2.99.
7
Secretory Mevalonate Kinase Regulates Host Immune Response and Facilitates Phagocytosis.分泌型甲羟戊酸激酶调节宿主免疫反应并促进吞噬作用。
Front Cell Infect Microbiol. 2021 Apr 26;11:641985. doi: 10.3389/fcimb.2021.641985. eCollection 2021.
8
The host mTOR pathway and parasitic diseases pathogenesis.宿主 mTOR 通路与寄生虫病发病机制。
Parasitol Res. 2021 Apr;120(4):1151-1166. doi: 10.1007/s00436-021-07070-6. Epub 2021 Feb 3.
9
activity of extract against the promastigote stage of cutaneous parasite, a member of complex isolates from Ghana.提取物对来自加纳的复合分离株成员之一的皮肤寄生虫前鞭毛体阶段的活性。
Access Microbiol. 2019 Sep 3;1(7):e000050. doi: 10.1099/acmi.0.000050. eCollection 2019.
10
Cytokine profile in Leishmania-positive blood donors.利什曼原虫阳性献血者的细胞因子谱。
PLoS One. 2020 Sep 23;15(9):e0238933. doi: 10.1371/journal.pone.0238933. eCollection 2020.